Marker Therapeutics, Inc. (MRKR)
1.11
-0.21
(-15.91%)
USD |
NASDAQ |
Nov 20, 16:00
0.98
-0.13
(-11.71%)
After-Hours: 20:00
Marker Therapeutics Gross Profit (TTM) : 0.00 for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.00 |
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 3.763M |
| September 30, 2023 | 6.107M |
| June 30, 2023 | 9.014M |
| March 31, 2023 | 8.966M |
| December 31, 2022 | 5.333M |
| September 30, 2022 | 3.410M |
| June 30, 2022 | -0.3021M |
| March 31, 2022 | -1.036M |
| December 31, 2021 | -1.921M |
| September 30, 2021 | -2.808M |
| June 30, 2021 | -2.391M |
| March 31, 2021 | -1.608M |
| December 31, 2020 | -0.9367M |
| September 30, 2020 | -0.4713M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.1595M |
| March 31, 2020 | -0.2337M |
| December 31, 2019 | -0.2058M |
| September 30, 2019 | -0.2058M |
| June 30, 2019 | -0.129M |
| March 31, 2019 | 0.1513M |
| December 31, 2018 | 0.206M |
| September 30, 2018 | 0.206M |
| June 30, 2018 | 0.3891M |
| March 31, 2018 | 0.1831M |
| December 31, 2017 | 0.1831M |
| September 30, 2017 | 0.1831M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Rigel Pharmaceuticals, Inc. | 258.34M |
| ACADIA Pharmaceuticals, Inc. | 1.088B |
| Alnylam Pharmaceuticals, Inc. | 3.874B |
| Anika Therapeutics, Inc. | 78.26M |
| Savara, Inc. | -0.301M |